Table 1. Clinical Characteristics of BLCA Patients and TP53 status in TCGA.
Characteristics | TP53 status | P value | |
---|---|---|---|
Wild type | Mutated | ||
Mean Age, years | 67.54 | 68.75 | |
Range | 34–90 | 44–90 | |
Gender | P = 0.7853 | ||
Female | 54 | 53 | |
Male | 156 | 144 | |
Tumor T stage | P = 0.6904 | ||
T1 | 2 | 2 | |
T2 | 23 | 14 | |
T2a | 15 | 11 | |
T2b | 30 | 26 | |
T3 | 23 | 19 | |
T3a | 30 | 41 | |
T3b | 42 | 39 | |
T4 | 4 | 7 | |
T4a | 25 | 18 | |
T4b | 2 | 2 | |
N stage | P = 0.0166 | ||
N0 | 136 | 100 | |
N1 | 22 | 24 | |
N2 | 34 | 41 | |
N3 | 1 | 7 | |
NX | 14 | 22 | |
M stage | P = 0.0314 | ||
M0 | 112 | 79 | |
M1 | 5 | 6 | |
MX | 92 | 110 | |
AJCC neoplasm disease stage | P = 0.1580 | ||
Stage I | 2 | 0 | |
Stage II | 69 | 60 | |
Stage III | 77 | 63 | |
Stage IV | 60 | 74 | |
Neoplasm histologic grade | P = 0.0013 | ||
High | 190 | 193 | |
Low | 18 | 3 |
Note:
P < 0.05 was considered statistically significant. Chi-square test was used.